Los Angeles, CA, United States of America

Gilbert M Rishton

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 86(Granted Patents)


Location History:

  • Thousand Oaks, CA (US) (2002 - 2003)
  • Malibu, CA (US) (2005 - 2017)
  • Los Angeles, CA (US) (2015 - 2024)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
17 patents (USPTO):

Title: Gilbert M Rishton: Innovator in Neurodegenerative Disease Treatment

Introduction

Gilbert M Rishton is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of neurodegenerative disease treatment, holding a total of 17 patents. His work focuses on developing innovative pharmaceutical compositions aimed at addressing cognitive decline and related disorders.

Latest Patents

Rishton's latest patents include groundbreaking research on isoindoline compositions and methods for treating neurodegenerative diseases. One of his notable inventions involves isoindoline sigma-2 receptor antagonist compounds, which are designed to inhibit Abeta-associated synapse loss or synaptic dysfunction in neuronal cells. Additionally, he has developed pharmaceutical compositions that contain novel compounds for treating Alzheimer's disease and cognitive decline, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Gilbert M Rishton has worked with leading companies in the pharmaceutical industry, including Cognition Therapeutics, Inc. and Amgen Inc. His expertise and innovative approach have positioned him as a key figure in the development of treatments for neurodegenerative diseases.

Collaborations

Rishton has collaborated with notable professionals in his field, including Susan M Catalano and Gary Charles Look. These partnerships have further enhanced his research and contributions to the scientific community.

Conclusion

Gilbert M Rishton is a distinguished inventor whose work in neurodegenerative disease treatment has the potential to make a significant impact on patient care. His innovative patents and collaborations reflect his dedication to advancing medical research and improving the lives of those affected by cognitive decline.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…